tykhr
sign in
free sign up
Chromocell Therapeutics Corporation
Biotechnology
Healthcare
CHRO
6.13 M shares
NYSE MKT US
traded
02 Sep 2025
listed
no
open
25.95
52 week high
25.95
high
26.02
52 week low
0.00
low
22.46
growth
0.00 %
previous Close
23.65
P/E ratio
market cap
7.78 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-1.69 M
4.34 %
eps
0.00 %
6.45 %
eps surprise
-26.09 %
net profit margin
-169465500.00 %
0.00 %
operating incoming
-2.05 M
-16.11 %
net change in cash
-1.15 M
15.74 %
cash on hand
1.25 M
-47.82 %
cost of revenue
0.00 %
top